Wave's ALS-dementia drug crashes out after early-phase flop
Roche terminates second phase II schizophrenia tria
Pfizer diabetes drug tops Ozempic in weight loss
Moderna vets help launch new RNA venture with $300M
*please scroll down for all the latest news*
